For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

Despite more than 30 years of intensive research, we do not yet have an effective vaccine that protects against HIV-1. Such a vaccine would need to induce broadly neutralising antibodies (bNAbs), but attempts to develop such a vaccine have not been successful so far. Many immunogen design strategies for inducing bNabs through vaccination exploit the HIV-1 envelope glycoprotein trimer, a protein complex that mediates viral entry into a target cell. Ronald Derking’s research focuses on the antigenic structure of this protein complex.

Event details of Search for HIV 1 vaccine
Date 28 October 2016
Time 10:00 -11:00
Location Agnietenkapel
Room Location

R.  Derking: Antigenic Structure of the HIV-1 Envelope Glycoprotein Trimer.

Supervisor

Prof. B. Berkhout

Co-supervisor

Dr R.W. Sanders

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.